3rd Quarter - Report — W STRATEGIES, LLC for GLAXOSMITHKLINE (2010)

Firm

W STRATEGIES, LLC

Client

GLAXOSMITHKLINE

Income

$40,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Monitoring the implementation of the Patient Protection and Affordable Care Act, including provisions related to comparative effectiveness research.

Lobbyist	Covered position, as disclosed
DARREN WILLCOX	—

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Health Issues HCR

Monitoring the implementation of the Patient Protection and Affordable Care Act, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars.

Lobbyist	Covered position, as disclosed
DARREN WILLCOX	House Rules Comm Assoc, Subcomm Staff Dir.

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP)

Trade (domestic/foreign) TRD

Educating policymakers on GlaxoSmithKline intellectual property initiatives in developing world.

Lobbyist	Covered position, as disclosed
DARREN WILLCOX	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.